发明名称 Proliposomal testosterone formulations
摘要 Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with pharmaceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy.
申请公布号 US8957053(B2) 申请公布日期 2015.02.17
申请号 US201414149227 申请日期 2014.01.07
申请人 Tesorx Pharma, LLC;Western University Health Sciences 发明人 Betageri Guru V.;Thirucote Ramachandran;Kadajji Veeran Gowda
分类号 A61K9/48;A61P5/00;A61K31/56;A61K9/50;A61K9/20;A61K9/127;A61K31/568;A61K31/575;A61K9/10;A61K9/14;A61K9/19 主分类号 A61K9/48
代理机构 J.A. Lindeman & Co., PLLC 代理人 J.A. Lindeman & Co., PLLC
主权项 1. A proliposomal powder dispersion, consisting essentially of (a) native testosterone, (b) cholesterol, and (c) at least one phospholipid,wherein (a) and (b) are present in a weight ratio (a):(b) ranging from 1.0:0.05 to 1.0:0.30 and (a), (b) and (c) are present in a weight ratio of (a):((b)+(c)) ranging from 1.0:1.0 and 1.0:2.5.
地址 Menlo Park CA US